Excited to share our latest work uncovering distinct cancer cell states expressing nephrogenic developmental programs and their spatial relationships with the tumor microenvironment underlying resistance to immune checkpoint blockade in kidney cancer.
https://t.co/T21eNwoabk
🔬
@LabMassague giving the keynote talk at the EMBO Workshop on the Many Faces of Cancer Evolution - read his recent commentary in @CD_AACR calling for an organ-informed precision oncology framework that integrates these site-imposed metastatic programs https://t.co/NKEoDPS0qQ
The Massagué Lab recently celebrated the departure of two colleagues Kenta Kawasaki and Jean Etersque. Thank you or your contributions ! 🔬#msk https://t.co/VHVT83qKcO
✨Welcome to the Massagué Lab Bujamin Vokshi
Dr. Vokshi obtained his Ph.D at IGBMC in France. He is currently working on defining the epigenetic states of metastasis-initiating cells in lung cancer.
Excited to share our recent work on a new mechanism for dormant disseminated tumor cells to evade immune surveillance. The preprint is available on bioRxiv now. https://t.co/H7C2G0A4Zp
A new study led by MSK researchers found that the #TGFbeta and #RAS signaling pathways work together to spur the spread of cancer in lung adenocarcinoma, a leading cause of cancer deaths around the world. #lcsm
Learn more: https://t.co/eh9ARWa6vl
What do brain metastasis & Alzheimer’s disease have in common? Happy to share our @Cancer_Cell study https://t.co/PvIYAWkwVI, revealing that one answer is how microglia react to pathological stimuli. Our data & code are now publicly available. We welcome questions & discussion!